Literature DB >> 2112530

Influence of cocktails of labeled monoclonal antibodies on the localization of antibodies in human tumor xenografts.

Y Watanabe1, K Endo, T Saga, M Koizumi, H Sakahara, T Nakai, M Hosono, Z S Yao, M Kuroki, Y Matsuoka.   

Abstract

In order to evaluate the usefulness of cocktails of labeled monoclonal antibodies (MoAbs) recognizing different antigen molecules to localize human cancer xenografts, we have compared the potential of three MoAbs recognizing representative cancer-associated CA 19-9, 17-1A and CEA antigens when administered alone or in combination. Specific binding of radioiodinated F(ab')2 fragments of these three MoAbs was observed to human colorectal cancer cell lines SW1116, LS180 and Co-3. The percentage of in vitro cell binding of a cocktail of any two MoAbs to cancer cells was equal to the average of those obtained with the two MoAbs alone. The three MoAbs were preferentially localized in tumor tissues xenografted in nude mice. When cocktails of any two MoAbs were used, the obtained tumor-to-normal tissue ratios and percent of injected dose per gram of tumor were between the levels obtained for each MoAb when administered alone, in all three tumors transplanted in nude mice. These data suggest that, although cocktails of labeled MoAbs recognizing different antigens may extend the spectrum of tumor specificities, their use does not improve the tumor localization ability of MoAb-conjugates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112530      PMCID: PMC5918024          DOI: 10.1111/j.1349-7006.1990.tb02560.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


monoclonal antibody antibody carcinoembryonic antigen phosphate‐buffered saline bovine serum albumin
  26 in total

1.  Comparison of tumor targeting of mouse monoclonal and goat polyclonal antibodies to carcinoembryonic antigen in the GW-39 human tumor-hamster host model.

Authors:  R M Sharkey; F J Primus; D Shochat; D M Goldenberg
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

2.  Preclinical trials with combinations and conjugates of T101 monoclonal antibody and doxorubicin.

Authors:  R O Dillman; D L Shawler; D E Johnson; D L Meyer; J A Koziol; J M Frincke
Journal:  Cancer Res       Date:  1986-10       Impact factor: 12.701

3.  CO 17-1A and related monoclonal antibodies: their production and characterization.

Authors:  M Herlyn; Z Steplewski; D Herlyn; H Koprowski
Journal:  Hybridoma       Date:  1986-07

4.  Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess.

Authors:  T Lindmo; E Boven; F Cuttitta; J Fedorko; P A Bunn
Journal:  J Immunol Methods       Date:  1984-08-03       Impact factor: 2.303

5.  [Experimental studies on the tumor imaging using antibodies to human alpha-fetoprotein. 1. Fluctuations in the iodine-labeled antibody activities].

Authors:  H Sakahara; K Endo; T Nakashima; H Ohta; K Torizuka; K Okada; O Yoshida; H Hirai
Journal:  Kaku Igaku       Date:  1984-07

6.  Effect of tumor mass and antigenic nature on the biodistribution of labeled monoclonal antibodies in mice.

Authors:  Y Watanabe; K Endo; M Koizumi; Y Kawamura; T Saga; H Sakahara; M Kuroki; Y Matsuoka; J Konishi
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

7.  Semiquantitative in vitro binding assay of indium-111-labeled monoclonal antibodies to human cancer and normal tissues.

Authors:  Y Watanabe; K Endo; M Koizumi; H Sakahara; Y Kawamura; T Saga; J Konishi; G Ohshio; T Manabe; R Tobe
Journal:  J Nucl Med       Date:  1988-08       Impact factor: 10.057

8.  Radioimmunodetection of melanoma utilizing In-111 96.5 monoclonal antibody: a preliminary report.

Authors:  S E Halpern; R O Dillman; K F Witztum; J F Shega; P L Hagan; W M Burrows; J B Dillman; M L Clutter; R E Sobol; J M Frincke
Journal:  Radiology       Date:  1985-05       Impact factor: 11.105

9.  Improved radioimaging and tumor localization with monoclonal F(ab')2.

Authors:  R L Wahl; C W Parker; G W Philpott
Journal:  J Nucl Med       Date:  1983-04       Impact factor: 10.057

10.  Serum CA 19-9 concentrations and computed tomography findings in patients with pancreatic carcinoma.

Authors:  H Sakahara; K Endo; K Nakajima; T Nakashima; M Koizumi; H Ohta; A Hidaka; S Kohno; Y Nakano; A Naito
Journal:  Cancer       Date:  1986-04-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.